SML1630

Bendazac

≥98% (HPLC)

• Synonym(e): Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• Empirische Formel (Hill-System): C₁₆H₁₄N₂O₃
• CAS-Nummer: 20187-55-7
• Molekulargewicht: 282.29
• EG-Nummer: 243-569-2
• MDL-Nummer: MFCD00866158
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329825514
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 200
• Assay: ≥98% (HPLC)
• Form: powder
• Löslichkeit: DMSO: soluble ≥1 mg/mL; methanol: soluble ≥1 mg/mL
• Lagertemp.: 2-8°C
• SMILES String: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• InChIKey: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• Angaben zum Gen: human ... XDH(7498)

Beschreibung

Biochem./physiol. Wirkung

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3